INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 169 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $496,000 | -21.3% | 10,353 | +3.5% | 0.01% | -44.0% |
| Q1 2020 | $630,000 | -49.2% | 10,000 | 0.0% | 0.02% | +25.0% |
| Q4 2019 | $1,239,000 | +33.4% | 10,000 | -28.6% | 0.02% | +5.3% |
| Q3 2019 | $929,000 | -10.2% | 14,000 | +7.7% | 0.02% | -29.6% |
| Q2 2019 | $1,034,000 | -28.9% | 13,000 | 0.0% | 0.03% | -25.0% |
| Q1 2019 | $1,454,000 | +570.0% | 13,000 | +550.0% | 0.04% | +227.3% |
| Q4 2016 | $217,000 | -34.0% | 2,000 | 0.0% | 0.01% | -45.0% |
| Q3 2016 | $329,000 | +26.5% | 2,000 | +9.7% | 0.02% | 0.0% |
| Q2 2016 | $260,000 | -74.7% | 1,823 | -77.2% | 0.02% | -55.6% |
| Q1 2016 | $1,028,000 | -23.5% | 8,000 | -11.1% | 0.04% | -51.6% |
| Q4 2015 | $1,344,000 | -37.7% | 9,000 | -30.8% | 0.09% | -2.1% |
| Q3 2015 | $2,156,000 | -55.3% | 13,000 | -35.0% | 0.10% | -50.3% |
| Q2 2015 | $4,828,000 | -31.5% | 20,000 | -20.0% | 0.19% | -39.0% |
| Q1 2015 | $7,051,000 | +66.8% | 25,000 | -7.7% | 0.31% | +114.4% |
| Q4 2014 | $4,228,000 | -34.6% | 27,100 | -0.7% | 0.15% | -7.6% |
| Q3 2014 | $6,462,000 | +5.0% | 27,300 | +5.0% | 0.16% | +17.9% |
| Q2 2014 | $6,152,000 | -36.1% | 26,000 | -11.0% | 0.13% | -30.9% |
| Q1 2014 | $9,630,000 | +125.6% | 29,200 | -53.3% | 0.19% | +110.9% |
| Q4 2013 | $4,268,000 | -22.7% | 62,500 | -21.9% | 0.09% | +55.9% |
| Q3 2013 | $5,522,000 | +207.8% | 80,000 | +100.0% | 0.06% | +13.5% |
| Q2 2013 | $1,794,000 | – | 40,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |